| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Antony Cheudjeu | |
| P2860 | cites work | TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein | Q24339582 |
| Novel peptide inhibitors of angiotensin-converting enzyme 2. | Q31133376 | ||
| A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells | Q33581409 | ||
| Isolation and characterization of glycosaminoglycans in human plasma | Q34566026 | ||
| Glycosaminoglycans in the human cornea: age-related changes | Q35027316 | ||
| Control of chondrogenesis in limb-bud cell cultures by bromodeoxyuridine | Q35109400 | ||
| Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells | Q35129308 | ||
| The glycosaminoglycans of normal and arthritic cartilage | Q35572274 | ||
| Coconut-derived D-xylose affects postprandial glucose and insulin responses in healthy individuals | Q35675502 | ||
| The glycosaminoglycans of the human artery and their changes in atherosclerosis | Q35903544 | ||
| Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. | Q36059429 | ||
| D-Xylose as a sugar complement regulates blood glucose levels by suppressing phosphoenolpyruvate carboxylase (PEPCK) in streptozotocin-nicotinamide-induced diabetic rats and by enhancing glucose uptake in vitro | Q36547028 | ||
| Beneficial effect of xylose consumption on postprandial hyperglycemia in Korean: a randomized double-blind, crossover design | Q36686857 | ||
| Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes. | Q36942072 | ||
| The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. | Q37045970 | ||
| Serine proteases | Q37175533 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q37230656 | ||
| The binding of heparin to the extracellular matrix of endothelial cells up-regulates the synthesis of an antithrombotic heparan sulfate proteoglycan. | Q39973601 | ||
| Chemical modifications of algal mannans and xylomannans: effects on antiviral activity. | Q40306393 | ||
| Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. | Q40359764 | ||
| Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin | Q42125176 | ||
| Expression of externally-disposed heparin/heparan sulfate binding sites by uterine epithelial cells | Q42478823 | ||
| Effects of cycloheximide, brefeldin A, suramin, heparin and primaquine on proteoglycan and glycosaminoglycan biosynthesis in human embryonic skin fibroblasts | Q46447622 | ||
| On the weight of the skin. | Q47450230 | ||
| Normal organ weights in men: part II-the brain, lungs, liver, spleen, and kidneys | Q48766796 | ||
| A Discussion on the Regulation of Blood Flow and Pressure | Q50234963 | ||
| Streptococcus pneumoniae sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor. | Q53584956 | ||
| Effect of insulin and growth hormone on the synthesis of radiolabelled proteoglycans from cultured human arterial smooth-muscle cells. | Q54119763 | ||
| Heparan Sulfate Proteoglycans in Infection | Q57773159 | ||
| Comparative effects of glucose and xylose on blood pressure, gastric emptying and incretin hormones in healthy older subjects | Q62479038 | ||
| Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein | Q67012919 | ||
| Synthesis and secretion of an altered chondroitin sulfate proteoglycan | Q67017960 | ||
| Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic, and intracellular degradative pathways | Q68055528 | ||
| Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells | Q69652468 | ||
| The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging | Q70394263 | ||
| Decrease in the glycosaminoglycan content in the skin of diabetic rats. The role of IGF-I, IGF-binding proteins and proteolytic activity | Q71284372 | ||
| Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition | Q73098910 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q77320493 | ||
| Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins | Q78067811 | ||
| The action of insulin on the transport of glucose through the cell membrane | Q78634586 | ||
| Effect of insulin on D-xylose disappearance in diabetic patients | Q78836026 | ||
| SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor | Q88292103 | ||
| Xylosyltransferase 1 and the GAG Attachment Site | Q89011214 | ||
| ADAM17 inhibition may exert a protective effect on COVID-19 | Q91934668 | ||
| Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation | Q96687264 | ||
| Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions | Q97550549 | ||
| Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19 | Q98730787 | ||
| SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 | Q99707959 | ||
| Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives | Q101563850 | ||
| Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2 | Q102075238 | ||
| SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site | Q104739115 | ||
| COVID-19 Vaccine Rollout: will it affect the Rates of Vaccine Hesitancy in Africa? | Q105254138 | ||
| Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 | Q107098692 | ||
| Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors | Q107202129 | ||
| Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity | Q107272363 | ||
| TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells | Q107338266 | ||
| Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer | Q107376911 | ||
| Cell entry by SARS-CoV-2 | Q107392240 | ||
| Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2 | Q107466974 | ||
| Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection | Q108396534 | ||
| ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin | Q110245632 | ||
| Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission | Q110734076 | ||
| SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling | Q110734107 | ||
| Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2 | Q110951933 | ||
| Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes | Q111459829 | ||
| Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19 | Q111459830 | ||
| Access to Highly Purified Chondroitin Sulfate for Appropriate Treatment of Osteoarthritis: A Review | Q111459831 | ||
| In Vitro Analysis of the Anti-viral Potential of nasal spray constituents against SARS-CoV-2 | Q111459832 | ||
| Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2 | Q111459833 | ||
| Study of Volume, Weight and Size of Normal Pancreas, Spleen and Kidney in Adults Autopsies | Q111459834 | ||
| ADAM17/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID‐19 | Q111459835 | ||
| Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial | Q111459836 | ||
| UDP-D-Xylose : Proteoglycan Core Protein β-D-Xylosyltransferase: A New Marker of Cartilage Destruction in Chronic Joint Diseases | Q111459860 | ||
| OM-85 Broncho-Vaxom, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells | Q111459863 | ||
| The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19 | Q111459864 | ||
| Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina | Q111459865 | ||
| SARS-CoV-2: ACE inhibitors, disastrous or desirable? | Q111459866 | ||
| STUDIES OF TISSUE PERMEABILITY | Q111459867 | ||
| Access to and equitable distribution of COVID-19 vaccine in low-income countries | Q111459868 | ||
| Inflammatory arthritis in patients with COVID-19 | Q111459870 | ||
| Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process | Q111459871 | ||
| Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition | Q111459872 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmaceutical science | Q7180763 |
| camostat mesylate | Q23731028 | ||
| nafamostat mesylate | Q27252259 | ||
| D-xylose | Q75082498 | ||
| SARS-CoV-2 | Q82069695 | ||
| spike glycoprotein [SARS-CoV-2] | Q87917585 | ||
| P304 | page(s) | 1947 | |
| P577 | publication date | 2022-03-17 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites | |
| P478 | volume | 27 |
Search more.